Target intelligence / Profile preview

Fibrin scaffold

Molecular classification
Other (biomaterial, biopolymer scaffold—not receptor/enzyme/transporter/etc.)
01

Overview

A **fibrin scaffold** is a three-dimensional network formed by the polymerization of fibrin, a protein derived from the cleavage of fibrinogen by thrombin during the clotting cascade. This scaffold functions as a temporary matrix at injury sites, supporting cell adhesion, migration, proliferation, and tissue regeneration. In regenerative medicine, fibrin scaffolds are utilized as biomaterials for tissue engineering due to their biocompatibility and similarity to natural extracellular matrices. The properties of the scaffold—such as porosity, strength, and degradation—can be modified by altering the concentrations of thrombin, fibrinogen, and cross-linking agents (e.g., Factor XIIIa, genipin). Despite their natural suitability, fibrin scaffolds degrade quickly unless chemically stabilized, which can limit their effectiveness in some long-term clinical applications. Fibrin scaffolds are not "targets" in the therapeutic sense; rather, they are products or materials, so "Fibrin scaffold formation" is not a target per established target nomenclature.

Other names
Fibrin gelFibrin matrixFibrin networkFibrin-based scaffold
02

Mechanism of action

Not applicable for direct targeting; drugs may modulate fibrin formation (e.g., thrombin inhibitors, fibrinolytic agents act upstream or downstream)

03

Biological functions

Hemostasis (blood clot formation)Wound healingTissue regeneration scaffoldCell adhesion, migration, differentiation, proliferation support
04

Disease associations

Cardiovascular disease (clot formation/repair)Tissue injury (repair/regeneration scaffold)Other (broad biomedical and surgical use)
05

Safety considerations

Rapid degradation of scaffold (poor stability limits use in long-term applications, e.g., tissue engineering)Risk of clot formation/thromboembolic events when manipulating fibrin formation in vivoImmunogenicity and infection risk if derived from non-autologous or contaminated sources
06

Interacting drugs

Not applicable (drugs do not bind to a "fibrin scaffold" as a classical target; however, drugs may influence its formation—see description)
07

Biomarkers

Fibrin degradation products (for monitoring clot breakdown)D-dimer (as marker for clot lysis/thrombotic events)

Beyond the preview

Go deeper on Fibrin scaffold.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fibrin scaffold.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call